BeOne Medicines AG
- ONC
- NASDAQ
- Biotechnology
- Oncology Therapeutics
- BTK Inhibitors
$370.17
Today +0.30%Quote Oct 19, 2026, 08:00 PM UTC
+5.51%over the last month
Max drawdown −5.2%From 1-month high −1.0%3 months +16.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About BeOne Medicines
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
12,000
Founded
2010
Market value
$547.16B
Quote Oct 19
Floor
$363.30
1.9% below price
Resistance
$377.20
1.9% above price
Price vs analyst targets
14 analysts
Lowest target
$367.00Highest target
$459.00
$367.00Highest target
$459.00
- Price $370.17
- Average target $406.22
- Analysts' target range
The price is close to the lowest analyst target. Analysts' average target sits about 10% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ONCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free